115 related articles for article (PubMed ID: 19372547)
21. In vivo imaging of tumor-propagating cells, regional tumor heterogeneity, and dynamic cell movements in embryonal rhabdomyosarcoma.
Ignatius MS; Chen E; Elpek NM; Fuller AZ; Tenente IM; Clagg R; Liu S; Blackburn JS; Linardic CM; Rosenberg AE; Nielsen PG; Mempel TR; Langenau DM
Cancer Cell; 2012 May; 21(5):680-693. PubMed ID: 22624717
[TBL] [Abstract][Full Text] [Related]
22. Retinoic acid induces myogenin synthesis and myogenic differentiation in the rat rhabdomyosarcoma cell line BA-Han-1C.
Arnold HH; Gerharz CD; Gabbert HE; Salminen A
J Cell Biol; 1992 Aug; 118(4):877-87. PubMed ID: 1323566
[TBL] [Abstract][Full Text] [Related]
23. Phosphatase orphan 1 inhibits myoblast proliferation and promotes myogenic differentiation.
Peng Y; Yue F; Chen J; Xia W; Huang K; Yang G; Kuang S
FASEB J; 2021 Jan; 35(1):e21154. PubMed ID: 33140469
[TBL] [Abstract][Full Text] [Related]
24. MEK/ERK inhibitor U0126 affects in vitro and in vivo growth of embryonal rhabdomyosarcoma.
Marampon F; Bossi G; Ciccarelli C; Di Rocco A; Sacchi A; Pestell RG; Zani BM
Mol Cancer Ther; 2009 Mar; 8(3):543-51. PubMed ID: 19258428
[TBL] [Abstract][Full Text] [Related]
25. SIX1 reprograms myogenic transcription factors to maintain the rhabdomyosarcoma undifferentiated state.
Hsu JY; Danis EP; Nance S; O'Brien JH; Gustafson AL; Wessells VM; Goodspeed AE; Talbot JC; Amacher SL; Jedlicka P; Black JC; Costello JC; Durbin AD; Artinger KB; Ford HL
Cell Rep; 2022 Feb; 38(5):110323. PubMed ID: 35108532
[TBL] [Abstract][Full Text] [Related]
26. The chemokine SDF1 controls multiple steps of myogenesis through atypical PKCzeta.
Odemis V; Boosmann K; Dieterlen MT; Engele J
J Cell Sci; 2007 Nov; 120(Pt 22):4050-9. PubMed ID: 17971416
[TBL] [Abstract][Full Text] [Related]
27. Transforming growth factor-beta-induced inhibition of myogenesis is mediated through Smad pathway and is modulated by microtubule dynamic stability.
Zhu S; Goldschmidt-Clermont PJ; Dong C
Circ Res; 2004 Mar; 94(5):617-25. PubMed ID: 14739161
[TBL] [Abstract][Full Text] [Related]
28. Expression of myogenic regulatory factors during muscle development of Xenopus: myogenin mRNA accumulation is limited strictly to secondary myogenesis.
Nicolas N; Gallien CL; Chanoine C
Dev Dyn; 1998 Nov; 213(3):309-21. PubMed ID: 9825866
[TBL] [Abstract][Full Text] [Related]
29. Expression of myogenic regulating factors, Myogenin and MyoD, in two canine botryoid rhabdomyosarcomas.
Kobayashi M; Sakai H; Hirata A; Yonemaru K; Yanai T; Watanabe K; Yamazoe K; Kudo T; Masegi T
Vet Pathol; 2004 May; 41(3):275-7. PubMed ID: 15133178
[TBL] [Abstract][Full Text] [Related]
30. SV40 T antigen inhibits expression of MyoD and myogenin, up-regulates Myf-5, but does not affect early expression of desmin or alpha 7 integrin during muscle development.
Haider SR; Wang W; Kaufman SJ
Exp Cell Res; 1994 Feb; 210(2):278-86. PubMed ID: 7507852
[TBL] [Abstract][Full Text] [Related]
31. Serum from differently exercised subjects induces myogenic differentiation in LHCN-M2 human myoblasts.
Vitucci D; Imperlini E; Arcone R; Alfieri A; Canciello A; Russomando L; Martone D; Cola A; Labruna G; Orrù S; Tafuri D; Mancini A; Buono P
J Sports Sci; 2018 Jul; 36(14):1630-1639. PubMed ID: 29160161
[TBL] [Abstract][Full Text] [Related]
32. Ovarian Sertoli-Leydig cell tumor of intermediate grade with heterologous elements of rhabdomyosarcoma. A case report and a review of the literature.
Grove A; Vestergaard V
Ann Diagn Pathol; 2006 Oct; 10(5):288-93. PubMed ID: 16979522
[TBL] [Abstract][Full Text] [Related]
33. Paradoxical decrease in myf-5 messenger RNA levels during induction of myogenic differentiation by insulin-like growth factors.
Mangiacapra FJ; Roof SL; Ewton DZ; Florini JR
Mol Endocrinol; 1992 Dec; 6(12):2038-44. PubMed ID: 1337140
[TBL] [Abstract][Full Text] [Related]
34. Synergistic up-regulation of muscle LIM protein expression in C2C12 and NIH3T3 cells by myogenin and MEF2C.
Ji ZX; Du C; Wu GS; Li SY; An GS; Yang YX; Jia R; Jia HT; Ni JH
Mol Genet Genomics; 2009 Jan; 281(1):1-10. PubMed ID: 18987887
[TBL] [Abstract][Full Text] [Related]
35. SMYD1 and G6PD modulation are critical events for miR-206-mediated differentiation of rhabdomyosarcoma.
Coda DM; Lingua MF; Morena D; Foglizzo V; Bersani F; Ala U; Ponzetto C; Taulli R
Cell Cycle; 2015; 14(9):1389-402. PubMed ID: 25644430
[TBL] [Abstract][Full Text] [Related]
36. TBP-like protein (TLP) represses myogenesis via inhibition of the myogenin promoter.
Nakazato A; Maeda R; Ishikawa K; Suzuki H; Tamura TA
Biochem Biophys Res Commun; 2016 Oct; 479(4):814-819. PubMed ID: 27680312
[TBL] [Abstract][Full Text] [Related]
37. Strong immunostaining for myogenin in rhabdomyosarcoma is significantly associated with tumors of the alveolar subclass.
Dias P; Chen B; Dilday B; Palmer H; Hosoi H; Singh S; Wu C; Li X; Thompson J; Parham D; Qualman S; Houghton P
Am J Pathol; 2000 Feb; 156(2):399-408. PubMed ID: 10666368
[TBL] [Abstract][Full Text] [Related]
38. Bone morphogenetic protein-2 inhibits terminal differentiation of myogenic cells by suppressing the transcriptional activity of MyoD and myogenin.
Katagiri T; Akiyama S; Namiki M; Komaki M; Yamaguchi A; Rosen V; Wozney JM; Fujisawa-Sehara A; Suda T
Exp Cell Res; 1997 Feb; 230(2):342-51. PubMed ID: 9024793
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of the skNAC gene in human rhabdomyosarcoma cells enhances their differentiation potential and inhibits tumor cell growth and spreading.
Berkholz J; Kuzyniak W; Hoepfner M; Munz B
Clin Exp Metastasis; 2014 Dec; 31(8):869-79. PubMed ID: 25209525
[TBL] [Abstract][Full Text] [Related]
40. Biomechanical signals upregulate myogenic gene induction in the presence or absence of inflammation.
Chandran R; Knobloch TJ; Anghelina M; Agarwal S
Am J Physiol Cell Physiol; 2007 Jul; 293(1):C267-76. PubMed ID: 17392379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
